Indian Patents Act: Incentivising Innovation without compromising affordable healthcareApril 18 2013
By Sanjeev K Kapoor
The recent judgement of the Supreme Court of India in the case of Novartis AG v Union of India has highlighted the protective provisions of Indian Patents Act, 1970, as amended by the Patents (Amendment) Act, 2005, (Patents Act) which imbibe the intent of striking a balance between incentivising genuine innovation and larger public interest of making available quality medicine at affordable prices.
With a premium account you get:
- One year of unrestrcited access to previous interviews, columns and articles
- One year access to all archival material
- Access to all Bar & Bench reports